Vitruvian Partners LLP

CIK: 0001692590Latest portfolio: $139.2M · Q4 2025

Holdings

Total Value

$139.2M

New Positions

Closed Positions

Top Holdings

#	Stock	Shares	Value	% Portfolio	Change
1	HNGEHINGE HEALTH INC	1,250,000	$58.1M	41.73%	—
2	MQMARQETA	6,853,183	$32.6M	23.39%	—
3	CARGCARGURUS INC	472,959	$18.1M	13.03%	—
4	XMTRXOMETRY INC	191,919	$11.4M	8.20%	-43,741
5	GLBEGLOBAL-E	210,209	$8.3M	5.94%	+38K
6	MXCTGBXMAXCYTE	5,043,356	$7.8M	5.62%	—
7	RXSTRXSIGHT	278,865	$2.9M	2.09%	+48K

Sector Breakdown

Healthcare0.0% ($580.6B)

Consumer Cyclical0.0% ($181.4B)

Technology0.0% ($32.6M)

Industrials0.0% ($11.4M)

Unknown0.0% ($7.8M)

Filing History

Quarter	Filing Date	Portfolio Value	Holdings
Q4 2025	Feb 6, 2026	$139.2M	7
Q3 2025	Nov 10, 2025	$144.2B	7
Q2 2025	Aug 11, 2025	$164.2B	7
Q1 2025	May 8, 2025	$104.8B	6
Q4 2024	Feb 11, 2025	$116.2B	6

Fund Information

CIK0001692590

Most Recent FilingFeb 6, 2026

Number of Filings5

View on SEC EDGAR →

Vitruvian Partners LLP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $139.2M across 7 holdings. The largest position is HINGE HEALTH INC (HNGE), representing 41.7% of the portfolio. Compared to the previous quarter, the fund opened 0 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.